[Strength and specificity of the CMBA screening platform for bioactive molecules discovery]

Med Sci (Paris). 2015 Apr;31(4):423-31. doi: 10.1051/medsci/20153104017. Epub 2015 May 8.
[Article in French]

Abstract

Used as powerful chemical probes in Life science fundamental research, the application potential of new bioactive molecular entities includes but extends beyond their development as therapeutic drugs in pharmacology. In this review, we wish to point out the methodology of chemical libraries screening on living cells or purified proteins at the CMBA academic platform of Grenoble Alpes University, and strategies employed to further characterize the selected bioactive molecules by phenotypic profiling on human cells. Multiple application fields are concerned by the screening activity developed at CMBA with bioactive molecules previously selected for their potential as tools for fundamental research purpose, therapeutic candidates to treat cancer or infection, or promising compounds for production of bioenergy.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Data Interpretation, Statistical
  • Database Management Systems
  • Drug Discovery* / instrumentation
  • Drug Discovery* / methods
  • Drug Discovery* / standards
  • Drug Evaluation, Preclinical* / instrumentation
  • Drug Evaluation, Preclinical* / methods
  • France
  • Humans
  • Molecular Targeted Therapy / methods
  • Sensitivity and Specificity
  • Small Molecule Libraries* / standards
  • Small Molecule Libraries* / supply & distribution

Substances

  • Small Molecule Libraries